Sun Pharmaceutical Industries Ltd. settled claims worth $200 million in an antitrust case in Pennsylvania alleging that the ...

India business is expected to grow 10 to 12 percent YoY, driven by volume gains, in-licensing deals, and new launches.

Sun Pharmaceutical Industries Ltd. closed 11.49% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Discover the Sun Pharma Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Shares of Sun Pharmaceutical Ltd. were trading lower on Friday after the company announced settlement of an antitrust ...

This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Aurobindo Pharma, Sun Pharma, Maruti ...

Sun Pharmaceutical and its Taro Pharmaceutical subsidiary are washing their hands of another segment of a years-long antitrust debacle with a $200 million settlement. | The deal will clear all claims ...

Top pharma players Dr Reddy, Lupin, and Sun Pharma are reportedly recalling drugs from the US market as a result of manufacturing faults an product mix up, as per the US Food and Drug Administration ...

India's top drugmaker by revenue Sun Pharma on Monday launched its anti-baldness drug Leqselvi in the U.S., following the ...

Under the agreement, Sun Pharmaceutical Industries, Inc. and Taro will make a combined payment of $200 million in exchange for a full release of all claims brought against them by the End Purchaser ...

Sun Pharma, Lupin, and Dr Reddy's are recalling various drugs from the US market due to manufacturing issues and product ...